参考文献/References:
[1] 刘振良， 贾国渠. 阿托伐他汀序贯治疗对接受急症PCI术急性心肌梗死患者缺血修饰白蛋白的影响[J]. 介入放射学杂志， 2016， 25：755-758.
[2] Badings EA, Hermanides RS, The SHK, et al. Comparison of outcomes and intervention among patients with non-ST-segment elevation acute myocardial infarction of those with a left circumflex versus those with a non-left circumflex-related coronary artery （from the ELISA-3 trial）[J]. Am J Cardiol, 2018, 121: 1123-1128.
[3] Hebbal VP, Setty HS, Sathvik CM, et al. Acute ST-segment elevation myocardial infarction: the prognostic importance of lead augmented vector right and leads V7-V9[J]. J Nat Sci Biol Med, 2017, 8: 104-109.
[4] Li J, Li X, Wang Q, et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 （the China PEACE-Retrospective Acute Myocardial Infarction Study）: a retrospective analysis of hospital data[J]. Lancet, 2015, 385: 441-451.
[5] Galvao-Braga C, Cid-Alvarez AB, Redondo-Dieguez A, et al. Multivessel versus culprit-only percutaneous coronary intervention in ST-segment elevation acute myocardial infarction: analysis of an 8-year registry[J]. Rev Esp Cardiol （Engl Ed）, 2017,70:425-432.
[6] Jura M, Jaros?awska J, Chu DT, et al. Mest and Sfrp5 are biomarkers for healthy adipose tissue[J]. Biochimie, 2016, 124: 124-133.
[7] Ouchi N, Higuchi A, Ohashi K, et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity[J]. Science, 2010, 329: 454-457.
[8] 中华医学会心血管病学分会， 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病杂志， 2015， 43：380-393.
[9] 申文彬， 白?静， 杨?霞， 等. 血小板高反应性对冠状动脉钙化患者介入术后发生主要不良心血管事件的研究[J]. 中华老年心脑血管病杂志， 2016， 18：153-157.
[10] Dieker HJ, Liem SS, El Aidi H, et al. Pre-hospital triage for primary angioplasty: direct referral to the intervention center versus interhospital transport[J]. JACC Cardiovasc Interv, 2010, 3: 705-711.
[11] 杨文韬， 林开阳， 林?棱. 低密度脂蛋白胆固醇水平与ST段抬高型心肌梗死患者急诊经皮冠状动脉介入术后院内死亡的关系[J]. 创伤与急诊电子杂志， 2017， 5：100-105.
[12] 刘相应， 唐良秋， 范文茂， 等. 直接经皮冠状动脉介入治疗术前、术后血清心型脂肪酸结合蛋白水平与急性ST段抬高心肌梗死患者预后的相关性[J]. 中国介入心脏病学杂志， 2016， 24：433-438.
[13] Nakamura K, Sano S, Fuster JJ, et al. Secreted frizzled-related protein 5 diminishes cardiac inflammation and protects the heart from ischemia/reperfusion injury[J]. J Biol Chem, 2016, 291: 2566-2575.
[14] Kikuchi R, Nakamura K, Maclauchlan S, et al. An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease[J]. Nat Med, 2014, 20: 1464-1471.
[15] 严叶香， 车文良. 院前脉压对STEMI患者MACE发生率及心肌功能血清指标的影响[J]. 热带医学杂志， 2017， 17：1335-1339.
[16] 李灿林， 张志广， 陈卫英， 等. BNP浓度与男性STEMI患者冠脉病变的相关研究[J]. 中国医药科学， 2017， 7：179-181.
[17] Schulte DM, Müller N, Neumann K, et al. Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects[J]. PLoS One, 2012, 7: e32437.
[18] Bie ZD, Sun LY, Geng CL, et al. MiR-125b regulates SFRP5 expression to promote growth and activation of cardiac fibroblasts[J]. Cell Biol Int, 2016, 40: 1224-1234.
[19] Abraityte A, Vinge LE, Askevold ET, et al. Wnt5a is elevated in heart failure and affects cardiac fibroblast function[J]. J Mol Med （Berl）, 2017, 95: 767-777.
[20] Laeremans H, Hackeng TM, van Zandvoort MA, et al. Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction[J]. Circulation, 2011, 124: 1626-1635.
[21] Hagenmueller M, Riffel JH, Bernhold E, et al. Dapper-1 is essential for Wnt5a induced cardiomyocyte hypertrophy by regulating the Wnt/PCP pathway[J]. FEBS Lett, 2014, 588: 2230-2237.
相似文献/References:
[1]葛智儒,邱建平,陆纪德,等.合并慢性非梗死相关动脉完全阻塞患者急性ST段抬高心肌梗死直接PCI 预后分析[J].介入放射学杂志,2010,(09):678.
GE Zhiru,QIU Jianping,LU Jide,et al.Impact of primary PCI on early and long－term outcomes in patients with ST－elevation myocardial infarction combined with chronic total occlusion of non－infarct related artery[J].journal interventional radiology,2010,(03):678.
[2]郭志福,郑兴,秦永文.药物洗脱支架内血栓形成研究进展[J].介入放射学杂志,2007,(08):568.
GUO Zhi-fu,ZHENG Xing,QIN Yong-wen.Progress in the study of drug-eluting intra-stent thrombosis[J].journal interventional radiology,2007,(03):568.
[3]陈跃光,张大东,顾俊,等.冠状动脉介入诊疗中非离子型对比剂对肾功能的影响和氯沙坦的保护价值[J].介入放射学杂志,2007,(11):727.
CHEN Yue-guang,ZHANG Da-dong,GU Jun,et al.Protective effects of losartan in renal dysfunction during coronary angiography and intervention caused by low osmolar non-ionic contrast media[J].journal interventional radiology,2007,(03):727.
[4]蔡伟,张梅,姜铁民.真性红细胞增多症反复冠脉血栓1例[J].介入放射学杂志,2015,(07):650.
CAI Wei,ZHANG Mei,JIANG Tie-min.Polycythemia vera complicated by repeated coronary thrombosis: report of one case[J].journal interventional radiology,2015,(03):650.
[5]杨 洁,贾 颖,王鹤鸣.ST段抬高型心肌梗死患者PCI术后E/E’比值与心功能变化的相关性[J].介入放射学杂志,2020,29(10):978.
YANG Jie,JIA Ying,WANG Heming..The correlation between E/E’ ratio and cardiac function indexes in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention[J].journal interventional radiology,2020,29(03):978.
[6]刘小希,邹 文,孟刘坤,等.急性冠状动脉综合征患者PCI术后受体相互作用蛋白激酶1表达及其与支架内再狭窄的关系 [J].介入放射学杂志,2021,30(05):438.
LIU Xiaoxi,ZOU Wen,MENG Liukun,et al.The expression level of receptor-interacting protein kinase 1 in patients with acute coronary syndrome after PCI and its relationship with in-stent restenosis[J].journal interventional radiology,2021,30(03):438.